Neurostimulator with titration assist

US12263343B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12263343-B2
Application numberUS-202318234186-A
CountryUS
Kind codeB2
Filing dateAug 15, 2023
Priority dateJun 13, 2016
Publication dateApr 1, 2025
Grant dateApr 1, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A method of neurostimulation titration includes titrating a neurostimulation signal from a first set of parameters toward a target set of parameters according to a titration aggressiveness profile having a titration hold point. The method further includes receiving a hold indicator indicating that the titration has reached the titration hold point. The method further includes initiating an intermediate hold of the titrating of the neurostimulation signal in response to receiving the hold indicator. The method further includes receiving an indication of a titration resumption that discontinues the intermediate hold.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of titrating a neurostimulation signal delivered to a patient from an implantable pulse generator, the method comprising: titrating the neurostimulation signal from a first set of parameters toward a target set of parameters according to a titration aggressiveness profile having a titration hold point corresponding to a holding set of stimulation parameters, the holding set of stimulation parameters being a point in the titration aggressiveness profile at which the implantable pulse generator is configured to hold titration until a titration resumption is received from an external device; receiving a hold indicator indicating that the titration has reached the holding set of stimulation parameters; initiating an intermediate hold of the titrating of the neurostimulation signal in response to receiving the hold indicator; and receiving an indication of a titration resumption from the external device that discontinues the intermediate hold. 2. The method of claim 1 , wherein the receiving of the indication of the titration resumption is preceded by a time interval sufficient to allow the patient to at least one of obtain assistance from a health care provider or activate a sensor communicating with the implantable pulse generator. 3. The method of claim 1 , further comprising: subsequent to receiving the indication of the titration resumption, delivering the neurostimulation signal at the holding set of stimulation parameters associated with the titration hold point; and titrating the neurostimulation signal from the holding set of stimulation parameters toward the target set of parameters. 4. The method of claim 3 , wherein the hold indicator is a first hold indicator, the titration hold point is a first titration hold point, the holding set of stimulation parameters is a first holding set of stimulation parameters, the intermediate hold is a first intermediate hold, and the indication of the titration resumption is a first indication of a first titration resumption; and wherein the method further comprises: receiving a second hold indicator, the second hold indicator indicating that at least one of the neurostimulation signal is being delivered at a second holding set of stimulation parameters of a second titration hold point or a side effect is being experienced by the patient in response to the neurostimulation signal; initiating a second intermediate hold of the titrating of the neurostimulation signal in response to the second hold indicator; and receiving a second indication of a second titration resumption that discontinues the second intermediate hold. 5. The method of claim 4 , wherein the receiving of the second indication of the second titration resumption is preceded by a time interval sufficient to allow the patient to at least one of obtain assistance from a health care provider or activate a sensor communication with the implantable pulse generator. 6. The method of claim 1 , wherein the indication of the titration resumption includes an instruction to modify the neurostimulation signal to a second set of parameters; and wherein the method further comprises: subsequent to receiving the indication of the titration resumption, delivering the neurostimulation signal at the second set of parameters; and titrating the neurostimulation signal from the second set of parameters toward the target set of parameters. 7. The method of claim 6 , wherein the hold indicator is a first hold indicator, the titration hold point is a first titration hold point, the intermediate hold is a first intermediate hold, and the indication of the titration resumption is a first indication of a first titration resumption; and wherein the method further comprises: receiving a second hold indicator, the second hold indicator indicating that at least one of the neurostimulation signal is being delivered at a second holding set of stimulation parameters of a second titration hold point or a side effect is being experienced by the patient in response to the neurostimulation signal; initiating a second intermediate hold of the titrating of the neurostimulation signal in response to the second hold indicator; and receiving a second indication of a second titration resumption that discontinues the second intermediate hold. 8. The method of claim 7 , wherein the receiving of the second indication of the second titration resumption is preceded by a time interval sufficient to allow the patient to at least one of obtain assistance from a health care provider or activate a sensor communication with the implantable pulse generator. 9. The method of claim 1 , wherein the indication of the titration resumption is received from an external device indicating instructions to discontinue the intermediate hold. 10. The method of claim 1 , wherein the titration aggressiveness profile has a more aggressive level and a less aggressive level, the more aggressive level defined by at least one of the following as compared to the less aggressive level: a shorter time interval associated with a transition from the first set of parameters to the target set of parameters, a greater target intensity, or a greater increment value between parameter levels at subsequent titration steps. 11. A neurostimulation system capable of providing a neurostimulation signal to a patient, the neurostimulation system comprising: an implantable pulse generator that generates the neurostimulation signal according to a titration protocol executed by a processor; an electrode configured to deliver the neurostimulation signal to the patient; and a lead coupling the electrode to the implantable pulse generator, wherein the processor is configured to implement the titration protocol by issuing control signals that allow the implantable pulse generator to: titrate the neurostimulation signal from a first set of parameters toward a target set of parameters according to a titration aggressiveness profile having a titration hold point corresponding to a holding set of stimulation parameters, the holding set of stimulation parameters being a point in the titration aggressiveness profile at which the implantable pulse generator is configured to hold titration until a titration resumption is received from an external device; receive a hold indicator indicating that the titration has reached the holding set of stimulation parameters; initiate an intermediate hold of the titrating of the neurostimulation signal in response to receiving the hold indicator; and receive an indication of a titration resumption from the external device that discontinues the intermediate hold. 12. The neurostimulation system of claim 11 , wherein the receiving of the indication of the titration resumption is preceded by a time interval sufficient to allow the patient to at least one of obtain assistance from a health care provider or activate a sensor communicating with the implantable pulse generator. 13. The neurostimulation system of claim 11 , wherein the processor is further configured to issue additional control signals that allow the implantable pulse generator to: subsequent to receiving the indication of the titration resumption, deliver the neurostimulation signal at the holding set of stimulation parameters associated with the titration hold point; and titrate the neurostimulation signal from the holding set of stimulation parameters toward the target set of parameters. 14. The neurostimulation system of claim 13 , wherein the hold indicator is a first hold indicator, the titration hold point is a first titration hold point, the holding set of stimulation

Assignees

Inventors

Classifications

  • with automatic adjustment · CPC title

  • adapted for vagal stimulation (A61N1/36114 takes precedence) · CPC title

  • Applying electric currents by contact electrodes · CPC title

  • alternating or intermittent currents {(applying electric fields by inductive or capacitive coupling A61N1/40; microwave apparatus A61N5/02)} · CPC title

  • for implantation or insertion into the body, e.g. heart electrode (A61N1/06 takes precedence) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12263343B2 cover?
A method of neurostimulation titration includes titrating a neurostimulation signal from a first set of parameters toward a target set of parameters according to a titration aggressiveness profile having a titration hold point. The method further includes receiving a hold indicator indicating that the titration has reached the titration hold point. The method further includes initiating an inte…
Who is the assignee on this patent?
Livanova Usa Inc
What technology area does this patent fall under?
Primary CPC classification A61N1/36114. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Apr 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).